Loading…
Extracellular Vesicles and DAMPs in Cancer: A Mini-Review
Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular pattern...
Saved in:
Published in: | Frontiers in immunology 2021-10, Vol.12, p.740548-740548 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723 |
container_end_page | 740548 |
container_issue | |
container_start_page | 740548 |
container_title | Frontiers in immunology |
container_volume | 12 |
creator | Abu, Nadiah Rus Bakarurraini, Nurul Ainaa Adilah Nasir, Siti Nurmi |
description | Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process. |
doi_str_mv | 10.3389/fimmu.2021.740548 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533</doaj_id><sourcerecordid>2591228973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</originalsourceid><addsrcrecordid>eNpVkUtLxDAUhYMoKqM_wI106aZj3mlcCMP4BEURdRvS9EYjfWgy9fHvbR0VzSbhJvc75-YgtEPwlLFC7_vQNP2UYkqmimPBixW0SaTkOaOUr_45b6DtlJ7wsLhmjIl1tMG4ooRjtYn08fsiWgd13dc2ZveQgqshZbatsqPZ5XXKQpvNbesgHmSz7DK0Ib-B1wBvW2jN2zrB9vc-QXcnx7fzs_zi6vR8PrvIHZdikSvuHXjnCiF9qR0HVklXlEpbomWBidNgFeYSwEqoJHdUeuW9rEpbqcEmm6DzJbfq7JN5jqGx8cN0NpivQhcfjI2L0bVhUnDiSgqWSK6k1VCJQYorooQWw-wTdLhkPfdlA5WDdhi-_gf9f9OGR_PQvZpCCM6wHAB734DYvfSQFqYJafw920LXJ0OFJpQWWo1aZPnUxS6lCP5XhmAzJmi-EjRjgmaZ4NCz-9ffb8dPXuwTg7aXDA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2591228973</pqid></control><display><type>article</type><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><source>Open Access: PubMed Central</source><creator>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</creator><creatorcontrib>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</creatorcontrib><description>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2021.740548</identifier><identifier>PMID: 34721407</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Alarmins - immunology ; Animals ; cancer ; Carcinogenesis ; exosome ; Extracellular Vesicles - metabolism ; Humans ; Immunity ; Immunology ; Immunomodulation ; Neoplasms - immunology ; Neoplasms - therapy ; PRR ; TLR ; Toll-Like Receptors - metabolism ; Tumor Microenvironment</subject><ispartof>Frontiers in immunology, 2021-10, Vol.12, p.740548-740548</ispartof><rights>Copyright © 2021 Abu, Rus Bakarurraini and Nasir.</rights><rights>Copyright © 2021 Abu, Rus Bakarurraini and Nasir 2021 Abu, Rus Bakarurraini and Nasir</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</citedby><cites>FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554306/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554306/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34721407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abu, Nadiah</creatorcontrib><creatorcontrib>Rus Bakarurraini, Nurul Ainaa Adilah</creatorcontrib><creatorcontrib>Nasir, Siti Nurmi</creatorcontrib><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</description><subject>Alarmins - immunology</subject><subject>Animals</subject><subject>cancer</subject><subject>Carcinogenesis</subject><subject>exosome</subject><subject>Extracellular Vesicles - metabolism</subject><subject>Humans</subject><subject>Immunity</subject><subject>Immunology</subject><subject>Immunomodulation</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>PRR</subject><subject>TLR</subject><subject>Toll-Like Receptors - metabolism</subject><subject>Tumor Microenvironment</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtLxDAUhYMoKqM_wI106aZj3mlcCMP4BEURdRvS9EYjfWgy9fHvbR0VzSbhJvc75-YgtEPwlLFC7_vQNP2UYkqmimPBixW0SaTkOaOUr_45b6DtlJ7wsLhmjIl1tMG4ooRjtYn08fsiWgd13dc2ZveQgqshZbatsqPZ5XXKQpvNbesgHmSz7DK0Ib-B1wBvW2jN2zrB9vc-QXcnx7fzs_zi6vR8PrvIHZdikSvuHXjnCiF9qR0HVklXlEpbomWBidNgFeYSwEqoJHdUeuW9rEpbqcEmm6DzJbfq7JN5jqGx8cN0NpivQhcfjI2L0bVhUnDiSgqWSK6k1VCJQYorooQWw-wTdLhkPfdlA5WDdhi-_gf9f9OGR_PQvZpCCM6wHAB734DYvfSQFqYJafw920LXJ0OFJpQWWo1aZPnUxS6lCP5XhmAzJmi-EjRjgmaZ4NCz-9ffb8dPXuwTg7aXDA</recordid><startdate>20211015</startdate><enddate>20211015</enddate><creator>Abu, Nadiah</creator><creator>Rus Bakarurraini, Nurul Ainaa Adilah</creator><creator>Nasir, Siti Nurmi</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211015</creationdate><title>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</title><author>Abu, Nadiah ; Rus Bakarurraini, Nurul Ainaa Adilah ; Nasir, Siti Nurmi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alarmins - immunology</topic><topic>Animals</topic><topic>cancer</topic><topic>Carcinogenesis</topic><topic>exosome</topic><topic>Extracellular Vesicles - metabolism</topic><topic>Humans</topic><topic>Immunity</topic><topic>Immunology</topic><topic>Immunomodulation</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>PRR</topic><topic>TLR</topic><topic>Toll-Like Receptors - metabolism</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abu, Nadiah</creatorcontrib><creatorcontrib>Rus Bakarurraini, Nurul Ainaa Adilah</creatorcontrib><creatorcontrib>Nasir, Siti Nurmi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abu, Nadiah</au><au>Rus Bakarurraini, Nurul Ainaa Adilah</au><au>Nasir, Siti Nurmi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracellular Vesicles and DAMPs in Cancer: A Mini-Review</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2021-10-15</date><risdate>2021</risdate><volume>12</volume><spage>740548</spage><epage>740548</epage><pages>740548-740548</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Certain cancer therapy has been shown to induce immunogenic cell death in cancer cells and may promote tumor progression instead. The external stress or stimuli may induce cell death and contribute toward the secretion of pro inflammatory molecules. The release of damage-associated molecular patterns (DAMPs) upon induction of therapy or cell death has been shown to induce an inflammatory response. Nevertheless, the mechanism as to how the DAMPs are released and engage in such activity needs further in-depth investigation. Interestingly, some studies have shown that DAMPs can be released through extracellular vesicles (EVs) and can bind to receptors such as toll-like receptors (TCRs). Ample pre-clinical studies have shown that cancer-derived EVs are able to modulate immune responses within the tumor microenvironment. However, the information on the presence of such DAMPs within EVs is still elusive. Therefore, this mini-review attempts to summarize and appraise studies that have shown the presence of DAMPs within cancer-EVs and how it affects the downstream cellular process.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34721407</pmid><doi>10.3389/fimmu.2021.740548</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2021-10, Vol.12, p.740548-740548 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_36541cb2ea16476a9ed58b7471759533 |
source | Open Access: PubMed Central |
subjects | Alarmins - immunology Animals cancer Carcinogenesis exosome Extracellular Vesicles - metabolism Humans Immunity Immunology Immunomodulation Neoplasms - immunology Neoplasms - therapy PRR TLR Toll-Like Receptors - metabolism Tumor Microenvironment |
title | Extracellular Vesicles and DAMPs in Cancer: A Mini-Review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A44%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracellular%20Vesicles%20and%20DAMPs%20in%20Cancer:%20A%20Mini-Review&rft.jtitle=Frontiers%20in%20immunology&rft.au=Abu,%20Nadiah&rft.date=2021-10-15&rft.volume=12&rft.spage=740548&rft.epage=740548&rft.pages=740548-740548&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2021.740548&rft_dat=%3Cproquest_doaj_%3E2591228973%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-74fcefcc856fb9c4e3d6c8b79a196801c9ea7046eea6ed64c26f7ff6dbad74723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2591228973&rft_id=info:pmid/34721407&rfr_iscdi=true |